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Prolonged survival of long-lived antibody-secreting cells in the BM has been implicated as a key compo-
nent of long-term humoral immunity. The current study was designed to uncover the extrinsic signals
required for the generation and maintenance of ASC in several niches (peritoneum, spleen and bone-mar-
row). Our results show that protein mixture of the Thalassophryne nattereri venom induced a chronic Th2
humoral response that is characterized by splenic hyperplasia with GC formation and venom retention by
follicular DCs. Retention of B1a in the BM were observed. In the late phase (120 d) of chronic venom-
response the largest pool of ASC into the peritoneal cavity consisted of B220negCD43high phenotype;
the largest pool of ASC into spleen was constituted by B220 positive cells (B220high and B220low), whereas
the largest pool of ASC into in the BM was constituted by the B220highCD43low phenotype; and ﬁnally,
terminally differentiated cells (B220negCD43high) were only maintained in the inﬂamed peritoneal cavity
in late phase. After 120 d a sustained production of cytokines (KC, IL-5, TNF-a, IL-6, IL-17A and IL-23) and
leukocytes recruitment (eosinophils, mast cells, and neutrophils) were induced. IL-5- and IL-17A-produc-
ing CD4+ CD44+ CD40L+ Ly6C+ effector memory T cells were also observed in peritoneal cavity. Finally,
treatment of venom-mice with anti-IL-5- and anti-IL17A-neutralizing mAbs abolished the synthesis of
speciﬁc IgE, without modifying the splenic hyperplasia or GC formation. In addition, IL-5 and IL-17A neg-
atively regulated the expansion of B1a in peritoneal cavity and BM, and promoted the differentiation of
these cells in spleen. And more, IL-5 and IL-17A are sufﬁcient for the generation of ASC B220neg in the
peritoneal cavity and negatively regulate the number of ASC B220pos, conﬁrming that the hierarchical
process of ASC differentiation triggered by venom needs the signal derived from IL-5 and IL-17A.
 2012 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Immunological memory is a hallmark of acquired immunity.
The contribution of B cells for the memory Abs response is based
on different population of cells: memory B cells and long-lived
antibody-secreting cells – ASC. Memory B cells undergo rapid clo-
nal expansion and differentiation to mount high afﬁnity Ab
responses upon exposure to antigens. ASC are terminally differen-
tiated and continue secreting Abs without antigenic stimulation in
the bone marrow (BM) that provides a special microenvironment
for their longevity [1–5].
Both memory B cells and ASC can be generated during the ﬁrst
immune response from innate-like B cells as B1 and conventional B
(B2) which differ in development, surface marker expression, tis-
sue localization, and function. Peritoneal B1 cells are comprised
of two different populations, B1a is CD5pos, long-lived andtory of Applied Toxinology,
05503-009 São Paulo, Brazil.
a).
er OA license.responsible for the production of low afﬁnity and polyreactive
IgM referred to as natural antibodies. Upon Ag encounter, they
quickly migrate to lymphoid organs (e.g., the spleen) to become
Ab-producing cells [6].
Numerous changes are associated with ASC differentiation
which distinguished then from memory conventional B cells,
including the loss of surface IgM, B220, CD19, and MHC class II,
the production of secretory IgM, and the upregulation of the spe-
ciﬁc marker as CD43, CD138 (syndecan-1) and CD93 [7–9]. ASC ex-
press adhesion molecules like VLA-4, VLA-5, CD9, CD44 [8–10] and
chemokines receptors as CXCR3 and CXCR4 [10–12], which could
be involved in homing and selective survival in particular tissues
or niches, mainly in the BM followed by spleen and sites of
inﬂammation.
The intrinsic genetic program that drives the differentiation of
ASC is becoming clear. ASC differentiation is largely controlled by
the transcriptional repressor B lymphocyte-induced maturation
protein-1 (Blimp-1) that neutralizes Pax5- and Bcl6-mediated
repression, thus enabling the expression of the plasma cell – spe-
ciﬁc gene program, in collaboration with other essential regulators
such as IFN regulatory factor (IRF) 4 and X-box-binding protein-1
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a proliferation-inducing ligand (APRIL, also known as TNFSF13)
have been associated with the survival of ASC [14,15]. Results from
Cassese et al. [16] strongly support the concept that ASC survival
depends on niches in which a combination of speciﬁc signals,
including IL-5, IL-6, stromal cell-derived factor-1a, TNF-a, and
ligand for CD44, provides an environment required to mediate
plasma cell longevity. Thus, the understanding of the mechanisms
by which ASC are generated and maintained is of fundamental
interest to reveal the basis of immunological memory.
The help that T cells provide to B cells allows the production of
memory B cells and ASC. The Th17 lineage develops in a pathway
independent from Th1 and Th2 differentiation [17,18]. A hallmark
of Th17 cells is the production of IL-17a-f, the proinﬂammatory
cytokines. These cytokines bind to multimeric IL-17 receptors
comprised of two IL-17RA subunits and one IL-17RC subunit [19].
Work has focused attention on the pathogenic function of the
IL-17A in several organ-speciﬁc autoimmune and chronic inﬂam-
matory diseases as SLE [20] and in particular, IL-17 has been
reported as the central cytokine involved in the spontaneous
development of germinal center (GC) B cell-derived autoantibodies
in autoimmune BXD2 mice [21]. However, the involvement of IL-
17A in the ASC differentiation and maintenance is still largely
unknown.
Thalassophryne nattereri ﬁsh envenomation is commonly re-
ported among ﬁshermen and bathers in the Brazilian North and
Northeast coast, estimated at hundreds of accidents per year
[22]. Using a mouse model, we have reveal the mechanism of ac-
tions of venom and its toxin families, and recently we shown that
low doses of T. nattereri venom mixed to alum for optimal condi-
tions of T cell activation elicited a strong and sustained (for more
than 6 months) active memory response with high levels of spe-
ciﬁc IgG1 and IgG2a, and total IgE, accompanied by a striking IL-
5 production and a decreased B220 expression in splenic B cells
[23]. Therefore, this model provides an interesting scenario for
studying the signals allowing survival and differentiation of the
memory B cells.
Thus in this work, we have used venom proteins of T. nattereri
Brazilian ﬁsh to establish a model in which germinal center de-
rived B cells and high afﬁnity speciﬁc antibodies were permanently
generated and to study the extrinsic signals required for the gener-
ation and maintenance of ASC in several niches (peritoneum,
spleen and bone-marrow) as well as the signaling pathways that
they engage.2. Material and methods
2.1. Mice
Male BALB/c mice (5–6 weeks old) were obtained from a colony
at the Butantan Institute, São Paulo, Brazil. Animals were housed in
a laminar ﬂow holding unit (Gelman Sciences, Sydney, Australia) in
autoclaved cages on autoclaved bedding, in an air-conditioned
room in a 12 h light/dark cycle. Irradiated food and acidiﬁed water
were provided ad libitum. All procedures involving animals were in
accordance with the guidelines provided by the Brazilian College of
Animal Experimentation (666/09 and 25/84/02).2.2. Induction of memory immune response and treatment of mice
with neutralizing antibody
T. nattereri ﬁsh venom was obtained from fresh captured spec-
imens at the Northeastern coast of Brazil (IBAMA 16221-1) in dif-
ferent months of the year according to Lopes-Ferreira et al. [24].
Endotoxin content was evaluated (resulting in a total dose<0.8 pg/ml LPS) with QCL-1000 chromogenic Limulus amoebocyte
lysate assay (Bio-Whittaker) according to the manufacturer’s
instructions. Groups of ﬁve mice were immunized with intraperi-
toneal injections of 10 lg of T. nattereri venom adsorbed in Al(OH)3
on day 0 and boosted on day 14 with the same dose of venom. Ani-
mals injected only with Al(OH)3 were considered as control mice.
All groups of animals (venom or control) were bled and killed at
days 21, 28, 48, 74 and 120. In some experiments mice were in-
jected i.v with 5 lg of neutralizing anti-IL-5 and anti-IL-17A mAbs
(R&D Systems Europe Ltd.) or control rat IgG mAb (GL113) 30 min
before venom injection at days 0 and 14. Mice were killed at 28 and
74 d after the ﬁrst immunization. For determination of leukocyte
recruitment into peritoneal cavity and T cell analysis mice were
immunized on day 0 with 10 lg of venom adsorbed in alum and
boosted on days 14, 20, 47 and 119 with 10 lg of venom and killed
at days 15, 21, 48 and 120 to detection of effector and memory
CD4+ T cells.2.3. Cell isolation
At time points indicated (21, 28, 48, 74, and 120 d) after venom
immunization, animals were killed by CO2 asphyxiation, and peri-
toneal cells were recovered by peritoneal ﬂushing using 5 ml of
ice-cold sterile PBS plus 0.1% EDTA (ethylenediaminetetraacetic
acid). BM cells were isolated from femur bones and after centrifu-
gation; the supernatant from both cell suspensions was collected
for cytokine, chemokine, and FACS analysis. Spleens were removed
aseptically and single-cell suspensions were prepared for FACS
analysis and in vitro re-stimulation. Cells were cultured at
2  106 cells/ml in RPMI 1640 medium supplemented with 2 mM
L-glutamine, 100 IU/ml penicillin, 100 lg/ml streptomycin,
25 mM HEPES buffer, and 10% heat-inactivated FCS (all from Life
Technologies, Paisley, UK). Cells were cultured with 10 lg/ml of
T. nattereri venom for 72 h, and the supernatants from parallel trip-
licate cultures were stored at 70 C until analysis of cytokine con-
centrations by ELISA.2.4. Flow cytometry analysis
For surface staining single-cell suspensions (1  106) were trea-
ted with 3% mouse serum of naive mice to saturate Fc receptors
followed by the staining by ﬂuorescence conjugated Abs: Rat
IgG2ak PE-anti-mouse CD5, Goat IgG2bk PE-anti-mouse Ig (speciﬁc
for IgG1, IgG2a, IgG2b and IgG3), Rat IgG2ak PerCP-Cy5-anti-
mouse CD45R/B220, Rat IgG2ak FITC-anti-mouse CD43, Rat IgG2ak
PE-anti-mouse CD138, Rat IgG2bk FITC-anti-mouse CD4, Rat
IgG2ak BIOTIN anti-mouse, second antibody goat PE anti-rat, Rat
IgG2bk FITC-anti-mouse Ly6C, Goat IgG2bk PE-anti-mouse CD154
(CD40L), Rat IgG2bk PE-anti-mouse Ly6G, Rat IgG2ak FITC-anti-
mouse CD117, Rabbit IgG2ak anti-mouse CCR3, goat FITC anti-rab-
bit for 30 min on ice. Cells were washed three times in PBS 1% BSA.
For intracellular staining, cells were stimulated with 20 ng/ml
acetate phorbol myristate, 1 lM iomycin (Sigma) e Golgi-stop
solution (BD Biosciences) for 6 h. Cells were washed, ﬁxed and per-
meabilized with Cytoﬁx/Cytoperm solution (BD Biociences) and
stained with Rat PerCP-Cy5 anti-mouse IL-17A, Rat PerCP-Cy5
anti-mouse IFN-c, Rat PerCP-Cy5 anti- mouse IL-4 and Rat PerCP-
Cy5 anti-mouse IL-5. Cells were washed three times in PBS 1%
BSA. Negative controls were used to set the ﬂow cytometer photo-
multiplier tube voltages, and single-color positive controls were
used to adjust instrument compensation settings. Cells were exam-
ined for viability by ﬂow cytometry using forward/side scatter
characteristics or dead cells were excluded by LIVE/DEAD ﬁxable
dead cell stain. Data from stained samples were acquired using a
FACSCalibur ﬂow cytometer equipped with CellQuest software
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ton–Dickinson, San Jose, CA).
2.5. Determination of cytokine and chemokine by ELISA
Cytokines and chemokines were measured in supernatant of
peritoneal and BM ﬂushing and splenic cell culture by a speciﬁc
two-site ELISA using antibody pairs purchased from Pharmingen
(BD, San Diego, CA, USA). Binding of biotinylated monoclonal anti-
bodies was detected using streptoavidin-horseradish peroxidase
complex and TMB (3,3’,5,5’-tetramethylbenzidine) substrate
solution containing hydrogen peroxide. Results are expressed as
picograms per milliliter in reference to commercially available
standards. Detection limits were 7.8 pg/ml for IL-1b, TNFa, IL-6,
IL-5, IL-17A, IFN-c and IL-10; for IL-23 was 39 pg/ml and for che-
mokine KC was 15.6 pg/ml. The results were expressed as the
mean values and standard deviations from ﬁve animals.
2.6. Titration of total IgE and speciﬁc IgG1 and IgG2a by ELISA
Blood samples were obtained by the puncture of the right
ventricle of immunized mice. ELISA for detection of Abs was
performed as described [25]. Plasma was tested for IgG1 or IgG2a
Abs using venom-coated 96-well plates and biotinylated goat
anti-mouse IgG1 or IgG2a antiserum. The reactions were devel-
oped with streptavidin-horseradish peroxidase complex (Sigma),
O-phenylenediamine (OPD) and H2O2 and the plates were read at
490 nm on an automated ELISA reader (Spectramax, Molecular
Devices). The results were expressed as the mean ± SEM absor-
bance. An IgE-speciﬁc ELISA was used to quantitate total IgE Ab
levels in plasma using matched Ab pairs (553413 Pharmingen
and 1130-08 Southern Biotech.), according to the manufacturer’s
instructions. Samples were quantiﬁed by comparison with a stan-
dard curve of IgE (0313ID, Pharmingen).
2.7. Passive cutaneous anaphylaxis (PCA)
For determination of the anaphylactic activity of IgE, PCA reac-
tions were performed in rats using non-inactivated plasma, accord-
ing to Mota and Wong [26]. After 18 h they were challenged i.v.
with 100 lg of venom +0.25% of Evans blue solution. All tests were
made in triplicate and PCA titers were expressed as the reciprocal
of the highest dilution that gave a lesion of >5 mm in diameter. The
detection threshold of the technique was established at 1:5
dilutions.
2.8. Determination of peritoneal inﬂux of cells
Groups of ﬁve mice were immunized i.p. with 10 lg of T. natter-
eri venom adsorbed in Al(OH)3 on day 0 and boosted on day 14
with the same dose of venom. Animals injected only with Al(OH)3
were considered as control group. At 120 d after the ﬁrst immuni-
zation, animals were killed by CO2 inhalation and peritoneal cells
were obtained by peritoneal ﬂushing with 5 ml of sterile PBS/EDTA
10 mM. For the recovery of cellular contents, lavage ﬂuid was
centrifuged at 378g for 10 min and the cell pellet was resuspended
in cold PBS/BSA 0.1% for leukocyte cell counts. Using a hemocytom-
eter and cytocentrifuge, slides were prepared, air dried, ﬁxed in
methanol, and stained (Wright-Giemsa, Scientiﬁc Products,
Chicago, IL). For differential cell counts, 300 leukocytes were enu-
merated and identiﬁed as macrophages, neutrophils, eosinophils or
mast cells based on staining and morphologic characteristics using
a light microscope (Nikon Eclipse E200). Representative photomi-
crographs of each group were acquired digitally using an Axio Im-
ager A1 microscope (Carl Zeiss, Germany) with an AxioCam ICc1
digital camera (Carl Zeiss, Germany).2.9. Histology and immunohistochemistry analysis of splenic sections
Spleens from control or venom-mice were collected and ﬁxed
(10% buffered formalin). The fragments were then dehydrated,
cleared and embedded in parafﬁn. Serial sagittal sections of the
whole spleen were made (3–4 lm thick), stained with hematoxi-
lin/eosin (H&E) to evaluate general morphology. Immunohisto-
chemistry was performed using mAbs against the membrane Ig
(Goat IgG2bk PE-anti-mouse Ig speciﬁc for IgG1, IgG2a, IgG2b
and IgG3 – Southern Biotech) or polyclonal antibodies against T.
nattereri venom obtained from pre-immunized mice. Endogenous
peroxidase was inhibited with 3% H2O2 in PBS for 10 min at room
temperature. Antibody binding in tissue sections for venom deter-
mination was visualized with a biotinylated secondary antibody
(goat anti-mouse), streptavidin and biotinylated horseradish per-
oxidase complex (StreptABComplex/HPE) and diaminobenzidine
(DAB) as chromogen. Sections were counterstained with hematox-
ilin/eosin. Negative control slides were processed in parallel with
each batch of staining or normal serum. All slides were examined
with light microscopy (Axio Imager A1, Carl Zeiss, Germany) cali-
brated with a reference micrometer slide. For each group of ﬁve
mice, four stained spleen sections from each mouse were analyzed
and it was performed three separate experiments.2.10. Statistical analysis
All values were expressed as mean ± SEM. Parametric data were
evaluated using an analysis of variance, followed by the Bonferroni
test. Non-parametric data were assessed using the Mann–Whitney
test. Differences were considered statistically signiﬁcant at
p < 0.05. Experiments were repeated at least three times.3. Results
3.1. Venom induces a chronic Th2 antibody response
BALB/c mice with high susceptibility to the development of
Th2-type immune response were immunized with proteins of
T. nattereri venom in the presence of adjuvant. After a venom boos-
ter without adjuvant, they were left for a period of at least 7 d and
up to 106 d in the absence of further antigenic stimulation for the
induction of a chronic response in accordance with McHeyzer-Wil-
liams et al. [27] (Fig. 1A). First, we focus our investigation on the
analysis of antibody memory response as a way to directly mea-
sure the activity of memory B cells, ex vivo (Fig. 1B) and the results
show a high production of venom-speciﬁc IgG1 and IgG2a accom-
panied by high levels of total and speciﬁc IgE antibodies compared
with control-mice. Until 74 d we observed an increase in the pro-
duction of IgG2a that decrease at 120 d. In contrast, the levels of
IgG1, total as well as speciﬁc IgE dramatically increase at 120 d
compared with 21–74 d. These results indicate that the chronic
interaction of venom proteins with host promotes a shift from
Th1 for Th2 in the late phase of antibody responses.
Besides the ability to produce speciﬁc antibodies, another as-
pect that is discussed on the formation of immunological memory
is the change in the spleen architecture, a lymphoid organ consid-
ered a center of lymphocyte proliferation and high-afﬁnity anti-
body production. Here we observed that spleens of venom-mice
appeared enlarged in size, and splenomegaly was accompanied
by an increased number of splenocytes (Fig. 1C). We observed that
typical B cells areas in lymphoid follicles of control-mice (Fig. 1D)
were modiﬁed in spleen of venom-mice with chronic immune re-
sponse at 120 d, showing an increased expansion of GC, largest
and most populous than in control-mice (Fig. 1E). In addition, a sig-
niﬁcant enhancement of Igpos B cells was seen in the regions of GC
BC
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Fig. 1. Venom induces a chronic Th2 antibody response. BALB/c mice (n = 5) were immunized i.p. with 10 lg of T. nattereri venom adsorbed in Al(OH)3 on day 0 and boosted
on day 14 with the same dose of venom alone. Animals injected only with Al(OH)3 were considered as control group. Mice were bled and killed at days 21, 28, 48, 74 and 120
(A). Plasma was tested for IgG1 or IgG2a antibodies using venom-coated 96-well plates and biotinylated goat anti-mouse IgG1 or IgG2a antiserum. Total IgE and venom-
speciﬁc IgE were determined by sandwich ELISA or PCA, respectively (B). Spleens appeared enlarged in size and the splenomegaly was accompanied by an increased number
of splenocytes (C). Typical B cell areas in lymphoid follicles were modiﬁed in venom-mice with chronic immune response (E, 120 d), showing an increased expansion of
germinal centers, largest and most populous than control-mice (D). A signiﬁcant enhancement of positive Ig B cells (Igpos) was seen in the regions of germinal center of
venom-mice (G) compared with control-mice (F). Scale bar, 100 lm. Mean ± SD of three independent experiments is shown. p < 0.05 compared to control-mice.
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L.Z. Grund et al. / Cytokine 59 (2012) 335–351 339of these venom-mice until 120 d (Fig. 1G) as compared to regions
of the GC of control-mice (Fig. 1F).
Together these results show that the protein mixture of the ve-
nom of T. nattereri induced a chronic humoral immune response
with a predominant production of IgG2a antibodies that decline
after 74 d privileging the production of IgE antibodies. The venom
induced the development of splenic hyperplasia with GC formation
and proliferation of positive Ig B lymphocytes.3.2. Bone marrow maintenance of B1a cells induced by venom
Although B1 cells are classiﬁed as B cells responding to T cell-
independent Ags, adaptive response and T cells can inﬂuence many
aspects of B1 cell activation and differentiation [28–30]. Next, we
analyzed B1a cells (B220/CD45RlowCD5pos) using antibodies
against B220 (anti-B cell isoform of CD45R) and CD5 in a negative
CD4 cells gate. The results present in Fig. 2 show that there was an
expansion of peritoneal B1a cells between 28 and 48 d (2.46% and
3.05%, respectively – Fig. 2A) that returned to control levels after
74 d. An elevated number of these cells were seen in spleen at
21, 28 and 74 d (9.72%, 8.48% and 5.45%, respectively – Fig. 2B);
we can observe an almost disappearance of B1a cells in spleen at
48 d and 120 d. Although few B1a cells were observed in BM of ve-
nom-mice compared with control-mice, this environment sus-
tained the chronic maintenance of B1a cells until 120 d (Fig. 2C).
Thus, these results demonstrate that venom induced the emer-
gence of B1a in the BM and spleen, followed by the mobilization
into the peritoneal cavity and retention in the BM.100 101 102 103 104
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Fig. 2. Accumulation of B1a cells subset. Determination of B1a by ﬂow cytometry using B
from immunized or control mice at various time points after immunization. Percentages
from pooled compartments each from ﬁve individual mice and three independent expe3.3. Venom antigens promote the ﬁnal differentiation of ASC in
inﬂamed tissue
The cellular differentiation of B memory cells into ASC has not
been completely elucidated, but a hierarchical model of differenti-
ation has been proposed: activated B cells progressively acquire
increasing levels of CD138 and decreasing levels of CD45R/B220
to ﬁnally arrive at B220neg ASC phenotype, which are either
CD138int or CD138high [9,31]. CD43 (leukosialin or sialophorin) is
a cell surface sialoglycoprotein implicated in cell adhesion and pro-
liferation whose tightly regulated expression in B lymphocytes is
likely important for their normal development and/or function [10].
In Fig. 3A we observed that the expression of B220 and CD43
divides this population into four subsets that persist at different
levels into all compartments. In peritoneal cavity venom induced
the formation of B220highCD43high, B220highCD43low, and
B220negCD43high. In spleen: B220highCD43high, B220lowCD43high,
and B220negCD43high; and ﬁnally in the BM: B220highCD43high,
B220highCD43low, and B220negCD43high.
In Fig. 3B, analyzing the expression of syndecan-1 – CD138 (his-
togram) in gated cells of the four subsets we show that venom in-
duced into the peritoneal cavity until 120 d the differentiation and
maintenance of B220highCD43highCD138pos, B220high
CD43lowCD138pos, and a bigger percentage of B220negCD43-
highCD138pos. Also, B220highCD43highCD138pos positive cells were
observed at 21 d; B220highCD43lowCD138pos positive cells were
detected at 21 d and 48 d; and B220negCD43highCD138pos were de-
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Fig. 3. Venom promotes the differentiation of ASC subtypes. The expression of B220 and CD43 divides the ASC population into 4 subsets that persist at different levels into all
compartments. In peritoneal cavity (Fig. 3A) venom induced the formation of B220highCD43high, B220highCD43low, and B220negCD43high. In spleen (Fig. 3B): B220highCD43high,
B220lowCD43high, and B220negCD43high; and ﬁnally in the BM (Fig. 3C): B220highCD43high, B220highCD43low, and B220negCD43high. Representative expression of high levels of CD138 in
gatedcells frompopulationof peritoneal cavity (D), spleen (E) andBM(F)weredetermined.Mean ± SEMof three independent experiments is shown. p < 0.05 compared to control-mice.
340 L.Z. Grund et al. / Cytokine 59 (2012) 335–351In spleen, B220highCD43highCD138pos and B220lowCD43highCD
138pos appeared at 21 d until 28 d and were maintained in chronicphase of venom response (120 d), but B220negCD43highCD138pos
were only detected at 48 d and 74 d after immunization (Fig. 3C).
L.Z. Grund et al. / Cytokine 59 (2012) 335–351 341In the BM (Fig. 3D) B220highCD43highCD138pos and B220high-
CD43lowCD138pos were maintained in chronic phase of venom re-
sponse (120 d), but B220negCD43highCD138pos were only observed
until 48 d.
Together, these results show that: (1) all compartments were
constituted by B220highCD43high and B220negCD43high, but the sub-
populations B220highCD43low and B220lowCD43high were only ob-
served in peritoneal cavity, and spleen, respectively; (2) in the
late phase (120 d) of chronic venom-response the largest pool of
ASC into the peritoneal cavity consist of B220negCD43high pheno-
type; the largest pool of ASC into spleen was constituted by B220
positive cells (B220high and B220low), whereas the largest pool of
ASC into in the BM was constituted by the B220highCD43low pheno-
type; (3) and ﬁnally, terminally differentiated cells (B220negCD43-
high) were only maintained in the inﬂamed peritoneal cavity in late
phase of chronic immune response induced by venom (120 d).3.4. Inﬂammatory as well T-derived cytokines are responsible for ASC
maintenance
A current concept of ASC homeostasis suggests that survival of
individual cells depends on speciﬁc signals like cytokines produced
in a limited number of ecological niches and, most of them present
in the BM, but also in inﬂamed tissues. The active mediators in-
duced by the venom until 120 d in the peritoneal cavity were KC
(Fig. 4A) and IL-5 (Fig. 4E), and produced by splenic cells were
TNF-a (Fig. 5C), IL-6 (Fig. 5D), IL-5 (Fig. 5E), IL-17A (Fig. 5F), and
IFN-c (Fig. 5H). In the BM, only IL-23 was produced at 120 d
(Fig. 6H).
Also, it was observed in peritoneal cavity the production of IL-
1b until 48 d (Fig. 4B), and TNF-a, until 28 d (Fig. 4C); the produc-
tion of IL-17A was observed only at days 48 and 74 (Fig. 4F); and
the production of IFN-c in this compartment was only observed
at 21 d (Fig. 4H). Splenic cells produced KC only at 28 d (Fig. 5A);
IL-1b was produced until 48 d (Fig. 5B); and IL-10 until 74 d
(Fig. 5G). Finally, in the BM venom induced the production of KC
until 28 d (Fig. 6A); IL-1b (Fig. 6B) and TNF-a (Fig. 6C) until 48 d;
IL-5 was induced until 74 d (Fig. 6E), and IL-17A and IL-10 were de-
tected only at 48 d (Fig. 6G).
Together the results from Figs. 3 and 4–6 suggest that the com-
bination of described positive regulators as KC, IL-5, and TNF-a,
and also IL-17A and IL-23 with negative regulators as IFN-c and
IL-10 could regulate the differentiation and the movement of cells
into and across the compartments analyzed. Also, the maintenance
of terminally differentiated cells (B220negCD43high) only in the in-
ﬂamed peritoneal cavity in late phase of chronic immune response
induced by venom could be related with the persistent production
of time KC, IL-5, TNF-a, IL-6, and IL-17A and IL-23.
Next we hypothesized that the resultant high level of peritoneal
KC and IL-5, and possibly systemic IL-6, TNF-a, and IL-17A could
contribute to leukocyte production and mobilization in the BM
and high peripheral cell numbers in venom-mice. We conﬁrm this
hypothesis with the demonstration that chronic humoral immune
response induced by T. nattereri venom is accompanied by a persis-
tent inﬂammatory reaction in the peritoneal cavity compared with
control animals (Fig. 7A). At 21 d an inﬂux of neutrophils and an
exuberant inﬂux of eosinophils to the peritoneal cavity of ve-
nom-mice were observed. At 48 d, venom induced an increase in
the number of neutrophils and a decrease in the number of eosin-
ophils recruited, but induced the inﬂux of macrophages. The late
phase of memory response (120 d) induced by venom was charac-
terized by a persistent Th2-mediated inﬂammation, with the inﬂux
of eosinophils, and mainly mast cells and neutrophils. At 120 d,
control animals show no inﬂammatory cells in the peritoneal
cavity.The most popular and well characterized hypothesis of long-
term antibody production is that memory B cells are stimulated
by persisting antigen that is retained in the form of antigen–anti-
body complexes on the surface of follicular dendritic cells – fDC
[32]. We next asked whether splenic cells of immunized mice re-
tained venom antigens. For this, we used speciﬁc serum produced
by previously venom-immunized mice according to Piran-Soares
et al. [33]. Immunohistochemistry analysis indicated that venom
proteins were detected in the clear zone of GC at days 21–48
(Fig. 7C–E) compared with control-mice (Fig. 7B). At 74 d
(Fig. 7F) and 120 d (Fig. 7G) after immunization, few amounts of
venom were seen retained by splenic cells, indicative of residual
antigen elimination from the cellular environment.
Taken together, these results demonstrate that the persistence
of venom antigens retained in fDCs of the spleen and the active
inﬂammation in peritoneal cavity generated the chronic produc-
tion of extrinsic factors capable to support the differentiation and
survival of ASC.
3.5. Peritoneum provides survival signals to sustain ASC differentiation
The idea that CD4 memory T cells (CD44hiCD62Lneg) can provide
accelerated help for antibody responses is well established. To de-
ﬁne the location of antigen-speciﬁc memory CD4+ T cells gener-
ated in a chronic response induced by venom, we have analyzed
memory CD4+ T cells expressing Ly6C and CD40L markers. Our re-
sults in Fig. 8A show that the venom induced a formation of mem-
ory CD4+ CD44+ T cells expressing high levels of both Ly6C (top
panel) and CD40L (bottom panel) in peritoneal cavity until 120 d.
In spleen persistent formation of CD4+ CD44+ T cells expressing
Ly6C was also observed until 49 d. In this compartment, CD4+
CD44+ T cells expressing CD40L were also seen in an early period
after immunization (15 d). Finally, in BM, only CD4+ CD44+ T cells
expressing high levels of Ly6C were detected at 49 d and 120 d. To-
gether, these results show that the late phase of chronic response
(120 d) induced by the venom is characterized by the presence
of memory CD4+ CD44+ T cells expressing high levels of both
Ly6C and CD40L in inﬂamed tissue and memory CD4+ CD44+ T
cells expressing Ly6C in the BM.
In Fig. 8B we conﬁrm the activation status of memory CD4 T
cells by the demonstration of the intracellular content of cytokines
14 d after immunization. In peritoneal cavity an elevated develop-
ment of IL-17A-, IL-5-, IL-4-, and IFN-c-producing CD4+ CD44+
memory T cells were observed compared to control-mice (an in-
crease of 3.3-fold, 3.02-fold, 2.86-fold, and 3.28-fold, respectively).
Also, in spleen venom induced the development of IL-5-producing
CD4+ CD44+ T cells 1.68-fold compared to control-mice), and IL-4-
and IL-5-producing CD4+ CD44+ T cells in BM (1.64-fold and 1.5-
fold, respectively). This result identiﬁes memory CD4+ CD44+ T
cells clones as a source of critical cytokines involved in Th2 shift
during the late phase of venom memory response.
Together, our results suggest that venom induced a Th2-medi-
ated inﬂammation in inﬂamed tissue with inﬁltration of eosino-
phils, mast cells, neutrophils, and CD4+ CD44+ CD40L+ Ly6C+
effector memory T cells. In addition, these results conﬁrm the par-
ticipation of memory CD4 T cells in the sustained production of
survival factors as IL-5 in all compartments and IL-17A only in in-
ﬂamed peritoneal cavity.
3.6. IL-5 and IL-17A cytokines positively regulate the production of
speciﬁc-IgE
We show that the resultant high level of peritoneal KC and IL-5,
and possibly systemic IL-5, IL-6, TNF-a, and IL-17A and bone-
marrow production of IL-23 could contribute to regulation of ASC
differentiation and maintenance. ASC survival is largely controlled
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Fig. 4. Inﬂammatory mediators as well T-derived cytokines produced by peritoneal cavity cells. The levels of KC (A), IL-1b (B), TNF-a (C), IL-6 (D), and IL-5 (E), IL-17A (F), IL-10
(G) and IFN-c (H) were determined by ELISA in the supernatant of peritoneal cavity of mice. p < 0.05 compared to control-mice.
342 L.Z. Grund et al. / Cytokine 59 (2012) 335–351by extrinsic factors such as interleukin IL-5, IL-6, SDF-1a, and TNFa
[16], but the direct or indirect inﬂuence of IL-5 and IL-17A in the
in vivo differentiation or maintenance of ASC is not known.
Next, we examined the ability of neutralizing mAbs against
both cytokines to modulate speciﬁc Ab responses generated by
T. nattereri venom (Fig. 9A). Mice treated with anti-IL-5 or anti-
IL-17A produced at 28 d after immunization diminished levels of
speciﬁc-IgG1 and undetectable amounts of speciﬁc-IgG2a com-
pared with mice inject with venom plus isotype control. However,
74 d after immunization, IgG1 and IgG2a antibody levels were
equally high in anti-IL-17A treated-mice, and elevated levels of
IgG2a were observed in anti-IL-5 treated-mice, but in contrast adiminished level of speciﬁc-IgG1 was observed in these mice
(Fig. 9B). These results show that the production of speciﬁc-IgG1
response against venom is controlled only by IL-5. We show that
the elevated total IgE levels observed in venom-mice were abol-
ished after anti-IL-5 treatment at 28 d, but not after anti-IL-17A
neutralization. Both treatments did not affect total IgE production
in later period (74 d) and moreover, the absence of both cytokines
virtually abolished the production of speciﬁc-IgE antibodies
(Fig. 9B), suggesting that IL-5 and IL-17A is crucial for the main-
taining of speciﬁc-IgE secreting cell functions.
Overall, these results suggest that IL-5 and IL-17A regulate the
production of speciﬁc-IgE, without modifying the production of
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Fig. 5. Mediators produced by splenic cells. The levels of KC (A), IL-1b (B), TNF-a (C), IL-6 (D), and IL-5 (E), IL-17A (F), IL-10 (G) and IFN-c (H) were determined by ELISA in the
supernatant of in vitro re-stimulated splenic cells. p < 0.05 compared to control-mice.
L.Z. Grund et al. / Cytokine 59 (2012) 335–351 343speciﬁc-IgG2a or the total production of IgE. Also, IL-5 seems to be
important for the chronic production of IgG1.
Nevertheless the treatment with neutralizing antibodies was
not able to reverse the splenomegaly (Fig. 9C) or the GC formation
(Fig. 9D), the absence of these cytokines during the immunization
period of time induced a decrease in total number of splenocytes in
74 d compared with both animals injected only with venom or
with venom plus control antibody GL113 (Fig. 9C). In addition,
the blockade of IL-17A impairs partially the increase of Igpos B cells
induced by the venom (lower panel, Fig. 9E).
Thus, although IL-5 and IL-17A regulate the synthesis of IgE
antibodies, both cytokines do not modify the splenic hyperplasia
or the formations of GC provoked by the venom; and also posi-
tively regulate the proliferation of splenocytes.3.7. IL-5 and IL-17A regulate the maintenance of B1a in spleen
In the Fig. 10A, we observed that the treatment of venom-mice
with blocking antibodies induced an expansion in the number of
B1a in the peritoneal cavity and in the BM at days 28 and 74,
suggesting a negative regulation of both cytokines in peripheral
compartments as inﬂamed peritoneal cavity and BM. But in con-
trast, the splenic B1a population induced by the venom decreased
dramatically after both treatments, suggesting a positive regula-
tion of both cytokines in B1a in a secondary lymphoid organ as
spleen.
Thus, IL-5 and IL-17A negatively regulate the expansion of B1a
in the peritoneal cavity and in BM, and in contrast, they control the
differentiation of these cells in spleen.
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344 L.Z. Grund et al. / Cytokine 59 (2012) 335–3513.8. IL-17A positively regulates the generation of terminally
differentiated ASC B220neg in inﬂamed tissue
The selection of allergen-speciﬁc B cells into ASC compartment
is a critical step in the immune deregulation that leads to the pro-
duction of IgE in allergic diseases [34]. We show that IL-5 and Il-
17A positively control the production of speciﬁc IgE in venom-mice.Next we examined the ability of neutralizing mAbs against both
cytokines to modulate the differentiation of ASC (Fig. 10B). We also
show that the treatment of venom-immunized mice with both
blocking antibodies resulted in almost complete depletion of ASC
with the phenotype B220negCD43high in peritoneal cavity at 74 d.
Also, both treatments promoted augmented percentage of ASC
with B220highCD43high phenotype. The normal percentage of the
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p < 0.05 compared to control-mice.
L.Z. Grund et al. / Cytokine 59 (2012) 335–351 345subpopulation B220highCD43low was not modiﬁed by neutralizing
antibodies.
In the spleen, both blocking neutralizing antibodies promoted a
higher percentage of ASC B220highCD43high (28 and 74 d) and
B220lowCD43high (74 d), however, they reduced the percentage of
ASC with B220lowCD43high phenotype at 28 d and B220neg
CD43highphenotype at 74 d.
Concerning to ASC in the BM, treatment with both anti-IL-5 and
anti-IL-17A mAbs promoted an increase in ASC B220highCD43high at
28 d, and in contrast, treatment with both blocking antibodies re-
sulted in almost complete depletion of ASC with the phenotype
B220negCD43high in BM at this time. Furthermore, anti-IL-5 mAbs
treatment induced at days 28 and 74 d an increased percentage
of ASC B220highCD43low. These experiments indicate that IL-5 and
IL-17A signals are sufﬁcient for the generation of ASC with the
B220neg phenotype, controlling negatively the rate of survival of
ASC with high B220 expression.Thus, IL-5 and IL-17A are sufﬁcient for the generation of ASC
B220neg in the peritoneal cavity and negatively regulates the num-
ber of ASC B220pos, conﬁrming that the hierarchical process of ASC
differentiation triggered by venom needs the signal derived from
IL-5 and IL-17A.4. Discussion
The aim of this study was to investigate the impact of IL-5 and
IL-17A on the development and maintenance of subtype of mem-
ory B cells in chronic humoral Th2 immune response. To this
end, we used chronic immunized mice with T. nattereri venom pro-
teins that were left for a period of 120 d in the absence of further
antigenic stimulation. In order to distinguish the differential sub-
types of memory B cells, the expression of B220 and CD43 markers
was evaluated in these cells in several niches (peritoneum, spleen
(A)
(B)
Fig. 8. Memory CD4 T cells were induced in response to T. nattereri venom. Representative dot plots showing 3-color staining for memory T cell identiﬁcation: gated double
positive CD4+CD44high cells were identiﬁed by the co-expression of Ly6C (Fig. 8A, top) or CD40L (Fig. 8A, bottom) in total of peritoneal cavity, spleen and BM from immunized
or control-mice at various time point after challenge. MFI were obtained via by ﬂow cytometry and each bar represents the mean ± SEM value from determinations from
pooled compartments each from ﬁve individual mice and three independent experiments. (B) In peritoneal cavity, spleen and BM of immunized or control-mice at 15 d,
CD4+CD44high T cells were analyzed for intracellular cytokines content using mAbs against IL-4, IL-5, IL-17A, and IFN-c. The production of memory T cell-derived cytokines
was calculated as fold increase induced by venom over the control group. p < 0.05 compared to control mice.
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Fig. 9. IL-5 and IL-17A cytokines positively regulate the production of speciﬁc-IgE. BALB/c mice were injected with neutralizing anti-IL-5 or anti-IL-17A mAbs or matched
isotype control 30 min before venom injection at days 0 and 14 (A). Plasma samples and spleen were isolated at 28 and 74 d after immunization. The isotypes of venom-
speciﬁc IgG and total or speciﬁc IgE present in the plasma of treated animals were determined by ELISA or PCA, respectively (B). The treatment with neutralizing antibodies
was not able to reverse the splenomegaly (C) or the germinal centers formation (D), but decreased the total number of splenocytes in 74 d compared with both animals
injected only with venom or with venom plus control antibody GL113 (C). The blockade of IL-17A impairs partially the increase of Igpos B cells induced by the venom (bottom,
E). p < 0.05 compared to control-mice, # p < 0.05 compared to untreated venom-mice.
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IL-17A or GL113 control mAbs 30 min before venom injection at days 0 and 14. Modulation of B1a cells by neutralizing antibodies treatment (A). Treatment with both
blocking mAbs resulted in almost complete depletion of ASC with the phenotype B220neg in peritoneal cavity and negatively regulated the differentiation of ASC with the
phenotype B220pos in all compartments (B). p < 0.05 compared to control-mice, # p < 0.05 compared to untreated venom-mice.
348 L.Z. Grund et al. / Cytokine 59 (2012) 335–351
L.Z. Grund et al. / Cytokine 59 (2012) 335–351 349and BM); and extrinsic survival factors as cytokines produced by
CD4 memory T cells and venom depot were also determined. Final-
ly, venom-immunized mice were treated before the immunization
processes with anti-IL-5- and anti-IL17A neutralizing antibodies
and the Abs production and differentiation of the subtypes of
ASC were investigated.
Two key transcriptional regulators, Blimp-1 and XBP-1, have
been shown to be necessary for the terminal differentiation of B
cells into long-lived antibody-secreting cells [6]. Little is known
about signals that induce Blimp-1 and XBP-1 although it has been
shown that the expression of Blimp-1 is induced by IL-5 [35]. IL-5
speciﬁcally binds to IL-5Ra and induces the recruitment of bc to IL-
5R, and at least three different signaling pathways including JAK2/
STAT5 pathway, Btk pathway, and Ras/ERK pathway are activated.
IL-5 critically regulates homeostatic proliferation and survival of
B1 cells and the natural antibody production by these cells, and en-
hances the AID and Blimp-1 expression in activated B2 cells lead-
ing to induce l to c1 class switch recombination and terminal
differentiation to IgM- and IgG1-secreting plasma cells, respec-
tively [36].
Since the demonstration the role of IL-23 in autoimmunity, it
was discovered that Th17 subset has been linked to the pathogen-
esis of many inﬂammatory diseases, including arthritis, experi-
mental autoimmune encephalitis, inﬂammatory bowel disease
and airway inﬂammation [20,37,38]. The differentiation of this
subtype of Th cell is dependent on IL-6–STAT3 activation of the
transcriptional regulator retinoic acid receptor-related orphan
receptor-ct (RORct); and these cells produce IL-17A, IL-17F, IL-21
and IL-22 and are highly responsive to IL-1 receptor 1 (IL-1R1)
and IL-23R signaling [17,39]. IL-17 has been reported as the central
cytokine involved in the spontaneous development of germinal
center B cell-derived autoantibodies in autoimmune BXD2 mice;
and promotes the prolonged retention of murine B cells in the
GC [21].
Nevertheless such data established a link between IL-5 and IL-
17 and B cells, the direct or indirect inﬂuence of IL-17 as well as
IL-5 in the in vivo differentiation or maintenance of subtype of
ASC is not known.
Several models have been proposed to account for the heteroge-
neity in memory B cell populations [3,10,27]. In contrast to models
of memory induced by acute infection with live pathogens that
have impaired long-term memory development, in this study, we
have used venom proteins of T. nattereri Brazilian ﬁsh to establish
a model in which germinal center derived B cells and high afﬁnity
speciﬁc antibodies were permanently generated. In particular,
memory response to venom induced a chronic expansion of B1a
cells in BM, while retains venom proteins by splenic cells and
maintains in the peritoneal cavity a Th2-mediated inﬂammation
with inﬁltration of eosinophils, mast cells, neutrophils and IL-
17A-producing CD4+ CD44+ CD40L+ Ly6C+ effector memory T cells
(TeM).
Furthermore, we have provided evidence that IL-17A as well as
IL-5 produced in a context of chronic inﬂammatory response
against venom proteins directly inﬂuence the production of spe-
ciﬁc IgE antibodies and the maintenance of B1a cells in the BM
from the spleen. Both cytokines negatively regulate the mainte-
nance of ASC B220pos in different sites of response. A striking ﬁnd-
ing in the current study was that IL-5 and IL-17A are critical for the
differentiation and maintenance of ASC with B220neg phenotype in
inﬂamed peritoneal cavity.
Some authors believe that the persistence of antigen, for
months or even years, in the form of immune complexes on the
surface fDC is an essential factor for the maintenance of memory
B cells and production of speciﬁc antibodies [32,40,41]. However,
even though antigen occupancy is apparently not required for
the maintenance of memory B cells as reported by Maruyamaet al. [42], our data here do not exclude the possibility that a BCR
signal is required for the maintenance of memory B cells and ASC
induced by the venom. Presumably these signals are similar to that
needed for the survival of naive B cells [43].
It is also conceivable that the B1a cells are required to initiate
T-independent B cell differentiation and Ig production. These cells
emigrate from the peritoneal cavity into spleen where they
complete their differentiation program and switch from IgM to
IgA/IgG-secreting B cells [44]. Furthermore, Zhong et al. [45] de-
scribed that B1 cells induced T cells to express IL-17 and IFN-c to
a much greater extent than observed with either B2 cells. Our data
showed here support the view that B1a cells emigrate from the
peritoneal cavity into spleen, where they are regulated by IL-5
and IL-17A to become ASC.
Mitsdoerffer et al. [46] have shown that Th17 cells are able to
promote class switching to IgG1, IgG2a, IgG2b, and IgG3. Finally
B1a cells encounter a survival niche into BM, where they may con-
tribute to activate IL-17A-producing CD4+ CD44+ Ly6C+ central
memory T cells (TcM) present in this compartment.
Class switched IgG1+ GC memory B cells were present in equiv-
alent percentage during all time in anti-IL-5- and anti-IL-17A-trea-
ted venom-mice compared with non-treated venom-mice (data
not shown) as well the treatments did not reverse the splenomeg-
aly or the GC formation (Fig. 9), further highlighting that signals
delivered via IL-5R and IL-17R are not required for GC mainte-
nance. Consistent with this we observed an elevated relative num-
ber of ASC with both phenotypes (B220high/low and in lesser extent
B220neg) in 74 d postimmunization in spleens obtained from anti-
IL-5- and anti-IL-17A-treated mice, indicating that in the splenic
niche, IL-5R and IL-17R signaling is not required for ﬁnal differen-
tiation into terminally-differentiated end stage cells with negative
expression of B220.
In addition, our studies deﬁne that signals delivered via the IL-
5R/IL-17R may directly support the differentiation of ASC B220neg
outside the GC, into a rich microenvironment necessary for long-
lasting survival as chronic inﬂamed tissues. This is supported by
data demonstrating that the treatment of venom-immunized mice
with anti-IL-5 and anti-IL-17A mAbs promotes the complete deple-
tion of ASC B220neg in peritoneal cavity. Also in untreated venom-
immunized mice we found that the presence of Th2 inﬂammation
with neutrophil, eosinophil and mast cells migrated to KC, IL-4 and
IL-5 chemokine gradient may be responsible for the attraction and
maintenance of IL-17A-producing effector memory CD4+ Th17
cells, which control the direct differentiation of ASC B220neg.
Future studies will need to characterize the direct action of
IL-17A and IL-5 in differentiation of ASC from memory B cells,
and if the different subsets of ASC induced by T. nattereri venom
possess differential functional subspecialties.
In addition, our results depicted here support a view [47] that
the physical co-localization in the inﬂamed peritoneal cavity of
leukocytes which induce the generation of BAFF/APRIL and possi-
ble COX2-derived lipidic mediators regulate the activation and dif-
ferentiation of ASC B220neg. Corroborating this view, it is also
demonstrated that non-haematopoietic cells as epithelial or endo-
thelial cells in inﬂamed peritoneal cavity contribute to ASC survival
by the production of BAFF and APRIL [15,48].
The population expansion and survival of Th17 cells depend on
IL-23 [49]. Interestingly, our data show a positive correlation of
the BM production of IL-23 and memory Th17 differentiation pro-
cess. Presumably, IL-23 in BM participates in the activating of
CD4+ CD44+ Ly6C+ central memory T cells into effector memory
cells expressing CD40L (CD154) thatmaybemobilized fromBM into
the inﬂamed tissue, an ideal niche for interaction with B cells [50–
53], amplifying the processes of differentiation and survival of ASC.
Antigen-speciﬁc IgE is the central event in the pathogenesis of
chronic atopic disorders (in atopic dermatitis, followed by atopic
Scheme 1. Possible scenario for the effect of IL-17A on differentiation and survival of ASC in inﬂamed tissue. We postulate that during chronic response to T. nattereri venom a
persistent peritoneal Th2-mediated inﬂammation consisting of the innate cells and inﬂammatory mediators as well T-derived cytokines produced by memory Th2 and Th17
cells promote a rich microenvironment that differentiates and maintains terminally differentiated cells (B220negCD43highCD138pos). The reservoir of splenic ASC was
constituted by B220 positive cells; in the BM IL-23 support TcM cells; and ASC B220pos were the major phenotype found in this compartment.
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and is dependent on Th2 cytokines. It is also important to discuss
that our study showed that speciﬁc IgE responses to venom were
ablated in anti-IL-5- and anti-IL-17-treated-mice, suggesting that
(i) IL-17A as well as IL-4 and IL-13 are key regulators of switching
to IgE, and (ii) combined therapies with anti-IL-5- and anti-IL-17-
monoclonal antibodies could be implemented. Moreover, our ﬁnd-
ings demonstrate that (iii) IL-17A is not involving in the IgG1
switch, in contrast to partial dependence of IgG1 on IL-5. Our study
produced results which corroborate the provocative ﬁndings of
Milovanovic et al. [54], showing that IL-17A has an important func-
tional implication in IgE production. Furthermore, they demon-
strated that blocking IL-17A affected only IgE and not IgG, IgM,
or IgA production in peripheral blood mononuclear cells (PBMCs)
from an atopic donor. Finally, our results enable us to propose a
mechanism in which IL-5 and IL-17A produced by CD4+ CD44+
CD40L+ Ly6C+ effector memory T cells induce memory B-cell IgE
class switching and differentiation into ASC.
Collectively, the observation described here that the production
of survival factors for the innate cells as neutrophils, eosinophils
and mast cells, and cytokines as IL-5 and IL-17A for activated effec-
tor memory T cells (CD40Lpos) guarantees the survival of the ASC
B220neg in the inﬂamed peritoneal cavity. IL-23 promotes in the
BM an ideal niche for retention of TcM in rest state (CD40Lneg) that
demonstrate fast capacity of mobilization for the inﬂamed tissue
where they are activated and will help ASC in survival. Thus, we
proposed that in our model, IL-5 and IL-17A is required for the dif-
ferentiation and maintenance of ASC with B220neg phenotype in in-
ﬂamed tissue as peritoneal cavity, regulating the down-expression
of B220 molecules in these cells (see Scheme 1).
5. Conclusion
In conclusion, by using venom proteins of T. nattereri Brazilian
ﬁsh we have highlighted the importance of extrinsic mediatorsas cytokines in Th2 chronic response development, demonstrating
that IL-5 and IL-17A are crucial for the maintaining of speciﬁc-IgE
secreting cell functions. We demonstrated that IL-5 and IL-17A ex-
ert positive regulation in B1a cells in a secondary lymphoid organ
as spleen and are crucial for the maintenance of speciﬁc-IgE pro-
duction. We found that IL-5 and IL-17A are required for the differ-
entiation and maintenance of ASC with B220neg phenotype in
inﬂamed peritoneal cavity, whereas neutralizing anti-IL-5- and
anti-IL-17A antibodies abolish this subpopulation. Thus, IL-5 and
IL-17A are sufﬁcient for the generation of ASC B220neg in the peri-
toneal cavity and negatively regulate the number of ASC B220pos,
conﬁrming that the hierarchical process of ASC differentiation trig-
gered by venom needs the signal derived from IL-5/IL-5R and IL-
17A/IL-17R.Acknowledgments
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